SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+19.44%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.38B
AUM Growth
+$2.38B
(+0.26%)
Cap. Flow
-$155M
Cap. Flow
% of AUM
-6.52%
Top 10 Holdings %
Top 10 Hldgs %
39.28%
Holding
113
New
41
Increased
19
Reduced
15
Closed
24
Top Buys
| 1 |
Nike
NKE
|
$58.3M |
| 2 |
Wynn Resorts
WYNN
|
$56.5M |
| 3 |
AT&T
T
|
$54.3M |
| 4 |
Biohaven
BHVN
|
$52.5M |
| 5 |
Colgate-Palmolive
CL
|
$50.8M |
Top Sells
| 1 |
Microsoft
MSFT
|
$89.1M |
| 2 |
Walt Disney
DIS
|
$87.4M |
| 3 |
Amazon
AMZN
|
$82.9M |
| 4 |
IQVIA
IQV
|
$72.7M |
| 5 |
Global Payments
GPN
|
$71.2M |
Sector Composition
| 1 | Healthcare | 46.26% |
| 2 | Consumer Discretionary | 16.29% |
| 3 | Industrials | 12.13% |
| 4 | Consumer Staples | 8.08% |
| 5 | Technology | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intuitive Surgical
ISRG
$158B
| $411K | 0.02% |
+1,550
| New | +$411K |
|
77
Stryker
SYK
$149B
| $406K | 0.02% |
+1,660
| New | +$406K |
|
78
Biogen
BIIB
$20.5B
| $396K | 0.02% |
+1,430
| New | +$396K |
|
79
Idexx Laboratories
IDXX
$50.7B
| $375K | 0.02% |
+920
| New | +$375K |
|
80
Waters Corp
WAT
$17.3B
| $325K | 0.01% |
+950
| New | +$325K |
|
81
BioMarin Pharmaceuticals
BMRN
$11.3B
| $276K | 0.01% |
+2,670
| New | +$276K |
|
82
CVS Health
CVS
$93B
| $267K | 0.01% |
+2,870
| New | +$267K |
|
83
Mettler-Toledo International
MTD
$26.1B
| $237K | 0.01% |
+164
| New | +$237K |
|
84
Bristol-Myers Squibb
BMY
$96.7B
| $236K | 0.01% |
+3,280
| New | +$236K |
|
85
Genmab
GMAB
$16.7B
| $221K | 0.01% |
+5,210
| New | +$221K |
|
86
Charles River Laboratories
CRL
$7.99B
| $220K | 0.01% |
+1,010
| New | +$220K |
|
87
Bio-Techne
TECH
$8.3B
| $215K | 0.01% |
+2,600
| New | +$215K |
|
88
Benitec Biopharma
BNTC
$365M
| $131K | 0.01% |
45,235
| – | – |
|
|
OHAAW
89
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
| $3.65K | ﹤0.01% |
72,605
| – | – |
|
90
Disc Medicine
IRON
$2.14B
| – | – |
-79,076
| Closed | -$3.89M |
|
91
Legend Biotech
LEGN
$6.64B
| – | – |
-274,200
| Closed | -$11.2M |
|
92
Marriott International Class A Common Stock
MAR
$72B
| – | – |
-134,800
| Closed | -$18.9M |
|
|
93
Microsoft
MSFT
$3.76T
| – | – |
-382,380
| Closed | -$89.1M |
|
|
94
Amazon
AMZN
$2.41T
| – | – |
-733,460
| Closed | -$82.9M |
|
95
Bolt Biotherapeutics
BOLT
$9.29M
| – | – |
-133,600
| Closed | -$3.96M |
|
|
96
Walt Disney
DIS
$211B
| – | – |
-926,850
| Closed | -$87.4M |
|
|
97
Global Payments
GPN
$21B
| – | – |
-658,992
| Closed | -$71.2M |
|
98
Heron Therapeutics
HRTX
$204M
| – | – |
-2,807,000
| Closed | -$11.8M |
|
99
Eli Lilly
LLY
$661B
| – | – |
-35,200
| Closed | -$11.4M |
|
100
Mastercard
MA
$536B
| – | – |
-181,691
| Closed | -$51.7M |
|